A Novel Cytokine-Antibody Fusion Protein, N-820, to Enhance the Functions of Ex-Vivo Expanded Natural Killer Cells Against Burkitt Lymphoma
Author Type(s)
Faculty
Document Type
Abstract
Publication Date
10-2022
Journal Title
Leukemia Research
Department
Pediatrics
Recommended Citation
Chu, Y., Nayyar, G., Su, N., Rosenblum, J., Soon-Shiong, P., Lee, J., Safrit, J., Barth, M., Lee, D., & Cairo, M. S. (2022). A Novel Cytokine-Antibody Fusion Protein, N-820, to Enhance the Functions of Ex-Vivo Expanded Natural Killer Cells Against Burkitt Lymphoma. Leukemia Research, 121 (Suppl.), S17-S18. https://doi.org/10.1016/S0145-2126(22)00214-4
COinS
